73 related articles for article (PubMed ID: 22392076)
1. The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.
Zhang J; Zhu L; Wei J; Liu L; Yin Y; Gu Y; Shu Y
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1057-62. PubMed ID: 22392076
[TBL] [Abstract][Full Text] [Related]
2. Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignancies.
Schmeel FC; Schmeel LC; Gast SM; Schmidt-Wolf IG
Int J Mol Sci; 2014 Aug; 15(8):14632-48. PubMed ID: 25196601
[TBL] [Abstract][Full Text] [Related]
3. Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells.
Bremm M; Pfeffermann LM; Cappel C; Katzki V; Erben S; Betz S; Quaiser A; Merker M; Bonig H; Schmidt M; Klingebiel T; Bader P; Huenecke S; Rettinger E
Front Immunol; 2019; 10():1218. PubMed ID: 31214182
[TBL] [Abstract][Full Text] [Related]
4. Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy.
Hwang A; Mehra V; Chhetri J; Ali S; Tran M; Roddie C
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539542
[TBL] [Abstract][Full Text] [Related]
5. Evolution of cell therapy for renal cell carcinoma.
Wang Y; Suarez ER; Kastrunes G; de Campos NSP; Abbas R; Pivetta RS; Murugan N; Chalbatani GM; D'Andrea V; Marasco WA
Mol Cancer; 2024 Jan; 23(1):8. PubMed ID: 38195534
[TBL] [Abstract][Full Text] [Related]
6. Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing.
Lee YY; Luo SC; Lee CH; Tang CL; Shen CC; Cheng WY; Yang YC; Yang MY; Yen CM
BMC Immunol; 2023 Jun; 24(1):14. PubMed ID: 37386444
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma.
Zhang Y; Wu X; Sharma A; Weiher H; Schmid M; Kristiansen G; Schmidt-Wolf IGH
Front Immunol; 2022; 13():925633. PubMed ID: 36091050
[TBL] [Abstract][Full Text] [Related]
8. Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials.
Zhang Y; Sharma A; Weiher H; Schmid M; Kristiansen G; Schmidt-Wolf IGH
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885117
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies.
Yang Y; Wang RQ; Zhong YM; Meng MY; Zhao YY; Yang LR; Li L; Hou ZL
J Healthc Eng; 2021; 2021():5709104. PubMed ID: 34540187
[TBL] [Abstract][Full Text] [Related]
10. Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma.
Zhang Y; Ellinger J; Ritter M; Schmidt-Wolf IGH
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32882824
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-induced killer cells co-cultured with non-cell derived targeting peptide-loaded dendritic cells induce a specific antitumor response.
Liu C; Cui X; Zhou D; Li C; Zhao M; Jin Y; Ding C; Zhu Y
Cancer Biol Ther; 2019; 20(5):720-728. PubMed ID: 30777479
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.
Merker M; Pfirrmann V; Oelsner S; Fulda S; Klingebiel T; Wels WS; Bader P; Rettinger E
Oncotarget; 2017 Sep; 8(39):66137-66153. PubMed ID: 29029499
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old.
Liu Y; Liu H; Liu H; He P; Li J; Liu X; Chen L; Wang M; Xi J; Wang H; Zhang H; Zhu Y; Zhu W; Ning J; Guo C; Sun C; Zhang M
Oncol Lett; 2016 Dec; 12(6):5205-5210. PubMed ID: 28105230
[TBL] [Abstract][Full Text] [Related]
14. Curative Effects of Dendritic Cells Combined with Cytokine-Induced Killer Cells in Patients with Malignant Pericardial Effusion.
Wang H; Cui Y; Wang S; Zhao R; Sun M
Med Sci Monit; 2016 Nov; 22():4159-4163. PubMed ID: 27806024
[TBL] [Abstract][Full Text] [Related]
15. Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy.
Du SH; Li Z; Chen C; Tan WK; Chi Z; Kwang TW; Xu XH; Wang S
PLoS One; 2016; 11(9):e0161820. PubMed ID: 27598655
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study.
Mu Y; Wang WH; Xie JP; Zhang YX; Yang YP; Zhou CH
Onco Targets Ther; 2016; 9():4617-27. PubMed ID: 27524915
[TBL] [Abstract][Full Text] [Related]
17. Effect of cytokine-induced killer cells on immune function in patients with lung cancer.
Pan Y; Wu Y; Ji J; Cai H; Wang H; Jiang Y; Sang L; Yang J; Gao Y; Liu Y; Yin L; Zhang LI
Oncol Lett; 2016 Apr; 11(4):2827-2834. PubMed ID: 27073559
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced killer (CIK) cells: from basic research to clinical translation.
Guo Y; Han W
Chin J Cancer; 2015 Mar; 34(3):99-107. PubMed ID: 25962508
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).
Schmeel LC; Schmeel FC; Coch C; Schmidt-Wolf IG
J Cancer Res Clin Oncol; 2015 May; 141(5):839-49. PubMed ID: 25381063
[TBL] [Abstract][Full Text] [Related]
20. Effects of cytokine-induced killer cell treatment combined with FOLFOX4 on the recurrence and survival rates for gastric cancer following surgery.
Liu H; Song J; Yang Z; Zhang X
Exp Ther Med; 2013 Oct; 6(4):953-956. PubMed ID: 24137296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
